rs2254522
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002340.6(LSS):c.1950T>C(p.His650=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 1,613,500 control chromosomes in the GnomAD database, including 44,346 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5320 hom., cov: 35)
Exomes 𝑓: 0.22 ( 39026 hom. )
Consequence
LSS
NM_002340.6 synonymous
NM_002340.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.66
Genes affected
LSS (HGNC:6708): (lanosterol synthase) The protein encoded by this gene catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
?
Variant 21-46194529-A-G is Benign according to our data. Variant chr21-46194529-A-G is described in ClinVar as [Benign]. Clinvar id is 677176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
?
Synonymous conserved (PhyloP=2.66 with no splicing effect.
BA1
?
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LSS | NM_002340.6 | c.1950T>C | p.His650= | synonymous_variant | 20/22 | ENST00000397728.8 | |
LSS | NM_001001438.3 | c.1950T>C | p.His650= | synonymous_variant | 20/23 | ||
LSS | NM_001145436.2 | c.1917T>C | p.His639= | synonymous_variant | 20/22 | ||
LSS | NM_001145437.2 | c.1710T>C | p.His570= | synonymous_variant | 19/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LSS | ENST00000397728.8 | c.1950T>C | p.His650= | synonymous_variant | 20/22 | 1 | NM_002340.6 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.252 AC: 38368AN: 152118Hom.: 5317 Cov.: 35
GnomAD3 genomes
?
AF:
AC:
38368
AN:
152118
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.257 AC: 64412AN: 250270Hom.: 9580 AF XY: 0.258 AC XY: 34941AN XY: 135446
GnomAD3 exomes
AF:
AC:
64412
AN:
250270
Hom.:
AF XY:
AC XY:
34941
AN XY:
135446
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.215 AC: 314667AN: 1461264Hom.: 39026 Cov.: 36 AF XY: 0.219 AC XY: 159331AN XY: 726916
GnomAD4 exome
AF:
AC:
314667
AN:
1461264
Hom.:
Cov.:
36
AF XY:
AC XY:
159331
AN XY:
726916
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.252 AC: 38382AN: 152236Hom.: 5320 Cov.: 35 AF XY: 0.257 AC XY: 19139AN XY: 74426
GnomAD4 genome
?
AF:
AC:
38382
AN:
152236
Hom.:
Cov.:
35
AF XY:
AC XY:
19139
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1355
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 02, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at